Interactive report guide
Quickly and easily understand how to interpret the Oncotype DX Breast DCIS Score report.
Only the Oncotype DX Breast DCIS Score report integrates clinicopathological features to provides an individualized risk assessment of 10-year local recurrence for DCIS patients. No other test can help you navigate the complexities of DCIS risk management to personalize your patient's treatment plan.
The Breast DCIS Score report:
QUANTIFIES 10-year risk of any local recurrence or an invasive local recurrence
CONFIRMED in a meta-analysis involving 773 patients
REFINED risk estimates with specified clinicopathologic features
INCREASES clarity and confidence in your patient's personalized treatment plan
Oncotype DX Breast DCIS Score Report and Meta-Analysis Overview
Our Director of Medical Affairs explains how the addition of tumor size and patient age increases the prognostic power of the Breast DCIS Score.